ReMDO Unveils Regulatory NavigatOR: A Guide through the Regenerative Medicine Regulatory Landscape
WINSTON-SALEM, NC – May 15, 2024 – The RegenMed Development Organization (ReMDO) announced today a…
The RegeneratOR, powered by the RegenMed Development Organization (ReMDO), is a dynamic initiative designed to propel regenerative medicine forward. By connecting innovators with resources, expertise, and talent, the RegeneratOR accelerates the journey from research to real-world cures, ensuring that patients benefit from new medical advancements faster than ever.
The RegeneratOR is built on five interconnected pillars:
This shared laboratory for start-ups and emerging companies grants access to advanced biomanufacturing equipment, expert guidance, and support for prototyping and early product development.
The accelerator not only provides valuable real estate but also the tools to validate market potential, create business strategies, and bring new therapies to patients.
Our workforce development program connects educational institutions with industry to create a skilled talent pipeline, including degree tracks to short-term courses, ensuring a workforce ready for the future of regenerative medicine.
Our network can connect you with 6 million patients and resources to fast-track product trials and commercialization.
Led by a former FDA section chief, this program will help accelerate FDA approvals and streamline clinical trials with real-world advice.
The RegeneratOR is more than a resource—it’s a launchpad for the companies, researchers, and innovators shaping the next generation of medical treatments.
Whether you are a start-up seeking support, a researcher moving toward commercialization, or an organization looking for skilled talent, The RegeneratOR is your pathway to success.
